SearcharxivSearch

arXiv subjects

Koyel Majumdar

Publications and source records attributed to Koyel Majumdar.

2 recordsLinked to original sources

Integrated differential analysis of multi-omics data using a joint mixture model: idiffomix

Gene expression and DNA methylation are two interconnected biological processes and understanding their relationship is important in advancing understanding in diverse areas, including disease pathogenesis, environmental adaptation, developmental biology, and therapeutic responses. Differential analysis, including the identification of differentially methylated cytosine-guanine dinucleotide (CpG) sites (DMCs) and differentially expressed genes (DEGs) between two conditions, such as healthy and affected samples, can aid understanding of biological processes and disease progression. Typically, gene expression and DNA methylation data are analysed independently to identify DMCs and DEGs which are further analysed to explore relationships between them. Such approaches ignore the inherent dependencies and biological structure within these related data. A joint mixture model is proposed that integrates information from the two data types at the modelling stage to capture their inherent dependency structure, enabling simultaneous identification of DMCs and DEGs. The model leverages a joint likelihood function that accounts for the nested structure in the data, with parameter estimation performed using an expectation-maximisation algorithm. Performance of the proposed method, idiffomix, is assessed through a thorough simulation study and application to a publicly available breast cancer dataset. Several genes, identified as non-differentially expressed when the data types were modelled independently, had high likelihood of being differentially expressed when associated methylation data were integrated into the analysis. The idiffomix approach highlights the advantage of an integrated analysis via a joint mixture model over independent analyses of the two data types; genome-wide and cross-omics information is simultaneously utilised providing a more comprehensive view.

stat.ME

A novel family of beta mixture models for the differential analysis of DNA methylation data: an application to prostate cancer

Identifying differentially methylated cytosine-guanine dinucleotide (CpG) sites between benign and tumour samples can assist in understanding disease. However, differential analysis of bounded DNA methylation data often requires data transformation, reducing biological interpretability. To address this, a family of beta mixture models (BMMs) is proposed that (i) objectively infers methylation state thresholds and (ii) identifies differentially methylated CpG sites (DMCs) given untransformed, beta-valued methylation data. The BMMs achieve this through model-based clustering of CpG sites and by employing parameter constraints, facilitating application to different study settings. Inference proceeds via an expectation-maximisation algorithm, with an approximate maximization step providing tractability and computational feasibility. Performance of the BMMs is assessed through thorough simulation studies, and the BMMs are used for differential analyses of DNA methylation data from a prostate cancer study. Intuitive and biologically interpretable methylation state thresholds are inferred and DMCs are identified, including those related to genes such as GSTP1, RASSF1 and RARB, known for their role in prostate cancer development. Gene ontology analysis of the DMCs revealed significant enrichment in cancer-related pathways, demonstrating the utility of BMMs to reveal biologically relevant insights. An R package betaclust facilitates widespread use of BMMs.

stat.ME